Small Boston-based biotech, Berg Pharma, is collaborating with hospitals and research teams to discover and validate the first-ever clinical biomarker to diagnose and treat pancreatic cancer. The cross-sector collaboration includes Berg, a biopharmaceutical company committed to uncovering health solutions through a data driven, biological research approach; the Cancer Center at …